// App-Quantinova.ai

: Liver function after stage 1 and MELD score prior to stage 2 are predictors of mortality after ALPPS. An analysis of 319 patients in the International ALPPS Registry

Researchers

Presenter

  • E. Schadde

Principal Investigators

  • H. Petrowsky

  • M. Lesurtel

  • A. Schnitzbauer

  • C. Tschor

  • M.A. Machado

  • R. Robles

  • M. Malago

  • V. Ardiles

  • E. DeSantibanes

  • P.-A. Clavien

Medical Centers

  • Kantonsspital Winterthur, Winterthur and Institute of Physiology, University of Zurich, Switzerland

  • Swiss HPB Center, Department of Surgery, University Hospital Zurich, Zurich, Switzerland

  • Department of Surgery, University Hospital Frankfurt, Johann-Wolfgang Goethe Universität, Frankfurt am Main, Germany

  • Department of Surgery, Sirio Libanes Hospital, University of Sao Paolo, Sao Paolo, Brazil

  • Department of General Surgery, Liver Transplant Unit, Virgen De La Ar- rixaca University Hospital, Murcia, Spain

  • Department of HPB and Liver Transplant Surgery, Royal Free Hospital, University College London, London, United Kingdom

  • Division of HPB Surgery, Liver Transplant Unit, Italian Hospital Buenos Aires, Buenos Aires, Argentina

Locations

  • Switzerland

  • Germany

  • Brazil

  • Spain

  • United Kingdom

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved